<code id='E3D81BC159'></code><style id='E3D81BC159'></style>
    • <acronym id='E3D81BC159'></acronym>
      <center id='E3D81BC159'><center id='E3D81BC159'><tfoot id='E3D81BC159'></tfoot></center><abbr id='E3D81BC159'><dir id='E3D81BC159'><tfoot id='E3D81BC159'></tfoot><noframes id='E3D81BC159'>

    • <optgroup id='E3D81BC159'><strike id='E3D81BC159'><sup id='E3D81BC159'></sup></strike><code id='E3D81BC159'></code></optgroup>
        1. <b id='E3D81BC159'><label id='E3D81BC159'><select id='E3D81BC159'><dt id='E3D81BC159'><span id='E3D81BC159'></span></dt></select></label></b><u id='E3D81BC159'></u>
          <i id='E3D81BC159'><strike id='E3D81BC159'><tt id='E3D81BC159'><pre id='E3D81BC159'></pre></tt></strike></i>

          explore

          explore

          author:leisure time    Page View:664
          Adobe

          Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

          Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

          advertisement

          When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Roche drug slashes death risk in early
          Roche drug slashes death risk in early

          Roche'sboothatthe2023ESMOconference.AndrewJoseph/STATMADRID—ARochedrugloweredtheriskofrecurrenceorde

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Cassava Sciences’ Alzheimer’s clinical trials should be halted

          MollyFerguson/STATTheFoodandDrugAdministrationshouldhaltCassavaSciences’ongoingclinicaltrialsinAlzhe